Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility? Smolenschi C, Rassy E, Pallud J, Dezamis E, et al. J Neurol 2023 Feb 22. doi: 10.1007/s00415-023-11600.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Smolenschi C, Rassy E, Pallud J, Dezamis E, et al. Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility? J Neurol 2023 Feb 22. doi: 10.1007/s00415-023-11600.
PMID: 36813928